Featured Article Kite and Shoreline Biosciences Enter Into Strategic Partnership To Develop Novel Allogeneic Cell Therapies June 17, 2021 | Featured, Press Releases Read More Shoreline Biosciences and BeiGene Announce Strategic Worldwide Collaboration to Develop and Commercialize Genetically Modified Natural Killer (NK) Cell Therapies June 9, 2021 | Featured, Press Releases Read More Recent articles Shoreline Biosciences Appoints Scott Forrest, PH.D., as Chief Business Officer October 12, 2021 | Press Releases Read More Shoreline Biosciences to Present at Upcoming Investor Conferences September 8, 2021 | Press Releases Read More Shoreline Biosciences Strengthens Senior Management Team With Three Key Hires July 13, 2021 | Press Releases Read More Shoreline Biosciences Appoints Mohammad El-Kalay, Ph.D. as Senior VP and Head of CMC June 28, 2021 | Press Releases Read More Kite and Shoreline Biosciences Enter Into Strategic Partnership To Develop Novel Allogeneic Cell Therapies June 17, 2021 | Featured, Press Releases Read More Shoreline Biosciences and BeiGene Announce Strategic Worldwide Collaboration to Develop and Commercialize Genetically Modified Natural Killer (NK) Cell Therapies June 9, 2021 | Featured, Press Releases Read More
